Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs

Molecular Pharmacology

Volumn 53, Issue 2, 1998, Pages 270-273

  Sjöberg, Anita Herrström ^a   Wang, Liya ^a   Eriksson, Staffan ^a,b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 2' ARABINOFLUORO 2' DEOXYADENOSINE; 2' DIFLUORO 2' DEOXYGUANOSINE; 2',3' DIDEOXYADENOSINE; ACICLOVIR; ANTILEUKEMIC AGENT; ANTIVIRUS AGENT; CLADRIBINE; CYTOSTATIC AGENT; DEOXYADENOSINE; DEOXYCYTIDINE; DEOXYGUANOSINE; DEOXYGUANOSINE KINASE; DEOXYINOSINE; DIDANOSINE; FLUCYTOSINE DEOXYRIBOSIDE; FLUDARABINE; GANCICLOVIR; GEMCITABINE; GUANINE ARABINOSIDE; MITOCHONDRIAL ENZYME; NUCLEOSIDE DERIVATIVE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIDARABINE;

ARTICLE; ENZYME SPECIFICITY; ESCHERICHIA COLI; HUMAN; PRIORITY JOURNAL;

EID: 0242560897     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.2.270     Document Type: Article

References (23)

1. Albertioni F, Spasokoutkotskaja T, Peterson B, Knaust E, Eriksson S, and Liliemark J (1997) Mechanism of 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA) resistance in a human lymphoid, CCRF-CEM cell line (abstract), in Proceedings of the American Association for Cancer Research, vol. 38; 1997 Apr 12-16; San Diego, CA. p. 103, American Association for Cancer Research, Philadelphia.
2. Arnér ESJ and Eriksson S (1995) Mammalian deoxyribonucleoside kinases. Pharmacol Ther 67:155-186.
3. Carson D, Wasson D, and Beutler E (1984) Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine. Proc Natl Acad Sci USA 81:2232-2236.
4. Carson D, Wasson D, Esparza L, Carrera C, Kipps T, and Cottam H (1992) Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine. Proc Natl Acad Sci USA 89:2970-2974.
5. Chabner BA (1996) Cytidine analogues, in Cancer Chemotherapy and Biotherapy (Chabner BA and Longo DL, eds) pp 213-233, Lippincott-Raven, Philadelphia.
6. Chottiner EG, Shewach DS, Datta NS, Ashcraft E, Gribbin D, Ginsburg D, Fox IH, and Mitchell BS (1991) Cloning and expression of human deoxycytidine kinase cDNA. Proc Natl Acad Sci USA 88:1531-1535.
7. Eriksson S and Wang L (1997) Substrate specificities, expression, and primary sequences of deoxynucleoside kinases; implications for chemotherapy. Nucleosides Nucleotides 16:653-659.
8. Gavel Y and von Heijne G (1990) Cleavage-site motifs in mitochondrial targeting peptides. Protein Eng 4:33-37.
9. Gentry GA (1992) Viral thymidine kinases and their relatives. Pharmacol Ther 54:319-355.
10. Gower WJ, Carr MC, and Ives DH (1979) Deoxyguanosine kinase. Distinct molecular forms in mitochondria and cytosol. J Biol Chem 154:2180-2183.
11. Harrison PT, Thompson R, and Davison AJ (1991) Evolution of herpesvirus thymidine kinases from cellular deoxycytidine kinase. J Gen Virol 72:2583-2586.
12. Johansson M and Karlsson A (1996) Cloning and expression of human deoxyguanosine kinase cDNA. Proc Natl Acad Sci USA 93:7258-7262.
13. T
14. Kurtzberg J (1993) Guanine arabinoside as a bone marrow-purging agent. Ann N Y Acad Sci 685:225-36.
15. Lotfi K, Liliemark J, Peterson B, Spasokoutkotskaja T, Eriksson S, and Albertioni F (1997) Cross-resistance between purine and pyrimidine analogs in human lymphoid cell lines, CCRF-CEM cells selected to resistance to cladribine and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (abstract). Proc Am Assoc Cancer Res 38:102.
16. Nakai K and Kanehisa M (1992) A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 14:897-911.
17. Park I and Ives DH (1988) Properties of a highly purified mitochondrial deoxyguanosine kinase. Arch Biochem Biophys 266:51-60.
18. Plunkett W and Saunders P (1991) Metabolism and action of purine nucleoside analogs. Pharmacol Ther 49:239-268.
19. Sarup JC and Fridland A (1987) Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides. Biochemistry 26:590-597.
20. Snyder FF, Jenuth JP, Dilay JE, Fung E, Lightfoot T, and Mably ER (1994) Secondary loss of deoxyguanosine kinase activity in purine nucleoside phosphorylase deficient mice. Biochim Biophys Acta 1227:33-40.
21. Wang L, Hellman U, and Eriksson S (1996) Cloning and expression of human mitochondrial deoxyguanosine kinase cDNA. FEBS Lett 390:39-43.
22. Wang L, Karlsson A, Arnér ESJ, and Eriksson S (1993) Substrate specificity of mitochondrial 2'-deoxyguanosine kinase efficient phosphorylation of 2-chlorode-oxyadenosine. J Biol Chem 268:22847-22852.
23. Yamada Y, Goto H, and Ogasawara N (1982) Deoxyguanosine kinase from human placenta. Biochim Biophys Acta 709:265-272.